Biomaterial Database

[Mode of action of kanamycin on Mycobacterium bovis, BCG (author's transl)]. 1974

K Oizumi, and N Kumano, and K Konno, and S Oka

UI	MeSH Term	Description	Entries
D007612	Kanamycin	Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.	Kanamycin A,Kanamycin Sulfate,Kantrex
D007930	Leucine	An essential branched-chain amino acid important for hemoglobin formation.	L-Leucine,Leucine, L-Isomer,L-Isomer Leucine,Leucine, L Isomer
D009163	Mycobacterium bovis	The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis.	BCG,Calmette-Guerin Bacillus
D010452	Peptide Biosynthesis	The production of PEPTIDES or PROTEINS by the constituents of a living organism. The biosynthesis of proteins on RIBOSOMES following an RNA template is termed translation (TRANSLATION, GENETIC). There are other, non-ribosomal peptide biosynthesis (PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT) mechanisms carried out by PEPTIDE SYNTHASES and PEPTIDYLTRANSFERASES. Further modifications of peptide chains yield functional peptide and protein molecules.	Biosynthesis, Peptide
D002250	Carbon Radioisotopes	Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.	Radioisotopes, Carbon
D003864	Depression, Chemical	The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical.	Chemical Depression,Chemical Depressions,Depressions, Chemical
D012333	RNA, Messenger	RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.	Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

K Oizumi, and N Kumano, and K Konno, and S Oka

[Carpal tunnel syndrome due to mycobacterium bovis BCG (author's transl)].

April 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,

K Oizumi, and N Kumano, and K Konno, and S Oka

Mechanism of Action of Isoniazid on Mycobacterium bovis Strain BCG.

April 1971, Infection and immunity,

K Oizumi, and N Kumano, and K Konno, and S Oka

[The effect of Mycobacterium bovis BCG-Praha on the growth of Daels' guinea-pig sarcoma (author's transl)].

June 1974, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,

K Oizumi, and N Kumano, and K Konno, and S Oka

[Studies on the mode of the immunopotentiating action of BCG (Part 2) (author's transl)].

November 1977, Kekkaku : [Tuberculosis],

K Oizumi, and N Kumano, and K Konno, and S Oka

Studies on the mode of the immunopotentiating action of BCG (Part 1) (author's transl).

October 1977, Kekkaku : [Tuberculosis],

K Oizumi, and N Kumano, and K Konno, and S Oka

Mycobacterium bovis (BCG) vaccination.

June 1992, The Medical journal of Australia,

K Oizumi, and N Kumano, and K Konno, and S Oka

Recombinant Mycobacterium bovis BCG.

November 2009, Vaccine,